Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Isenberg

Showing results (51-60 of 280) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Rheumatology|March 2, 2023
Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohortFrancisca Guimarães, Resit Yildirim, David A Isenberg
Rheumatology (Oxford, England)|September 10, 2022
Atacicept-it's not over until the wolf-lady sings (or maybe howls)David A Isenberg, Celia J F Lin
Arthritis Care & Research|October 22, 2020
Measures of Adult Systemic Lupus Erythematosus: Disease Activity and DamageShilpa Arora, David A Isenberg, Isabel Castrejon
Rheumatology (Oxford, England)|May 3, 2020
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?Pedro Gaspar, Hannah Cohen, David A Isenberg
Nature Clinical Practice. Rheumatology|February 1, 2008
Conversion of discoid lupus to antiphospholipid syndrome and SLEMichelle M A Fernando, David A Isenberg
Expert Opinion on Investigational Drugs|December 22, 2007
Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategyJose Maria Pego-Reigosa, David A Isenberg
Expert Review of Clinical Immunology|September 22, 2015
What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy?Andreia Vilas-Boas, Jyoti Bakshi, David A Isenberg
Nature Reviews. Rheumatology|December 12, 2012
Global trends, potential mechanisms and early detection of organ damage in SLEAnselm Mak, David A Isenberg, Chak-Sing Lau
Immunotargets and Therapy|June 26, 2020
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?Ana Lorenzo-Vizcaya, Serena Fasano, David A Isenberg
Journal of Immunological Methods|October 16, 2002
Optimisation of herpes simplex virus-based vectors for delivery to human peripheral blood mononuclear cellsKonstantina Papageorgiou, David A Isenberg, David S Latchman
Pageof 28

Showing results (51-60 of 280) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Rheumatology|March 2, 2023
Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohortFrancisca Guimarães, Resit Yildirim, David A Isenberg
Rheumatology (Oxford, England)|September 10, 2022
Atacicept-it's not over until the wolf-lady sings (or maybe howls)David A Isenberg, Celia J F Lin
Arthritis Care & Research|October 22, 2020
Measures of Adult Systemic Lupus Erythematosus: Disease Activity and DamageShilpa Arora, David A Isenberg, Isabel Castrejon
Rheumatology (Oxford, England)|May 3, 2020
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?Pedro Gaspar, Hannah Cohen, David A Isenberg
Nature Clinical Practice. Rheumatology|February 1, 2008
Conversion of discoid lupus to antiphospholipid syndrome and SLEMichelle M A Fernando, David A Isenberg
Expert Opinion on Investigational Drugs|December 22, 2007
Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategyJose Maria Pego-Reigosa, David A Isenberg
Expert Review of Clinical Immunology|September 22, 2015
What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy?Andreia Vilas-Boas, Jyoti Bakshi, David A Isenberg
Nature Reviews. Rheumatology|December 12, 2012
Global trends, potential mechanisms and early detection of organ damage in SLEAnselm Mak, David A Isenberg, Chak-Sing Lau
Immunotargets and Therapy|June 26, 2020
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?Ana Lorenzo-Vizcaya, Serena Fasano, David A Isenberg
Journal of Immunological Methods|October 16, 2002
Optimisation of herpes simplex virus-based vectors for delivery to human peripheral blood mononuclear cellsKonstantina Papageorgiou, David A Isenberg, David S Latchman
Pageof 28